Literature DB >> 4599880

Selective roles of thymus-derived lymphocytes in the antibody response. II. Preferential suppression of high-affinity antibody-forming cells by carrier-primed suppressor T cells.

T Takemori, T Tada.   

Abstract

Passive transfer of thymocytes and spleen cells from donors primed with keyhole limpet hemocyanin (KLH) caused significant decrease in the average avidity of anti-DNP antibodies produced by direct and indirect PFC in the recipients in both primary and adoptive secondary antibody responses against DNP-KLH. The analysis of the avidity distribution of antibodies produced by plaque-forming cells (PFC) indicated that the observed decrease in the average avidity is primarily due to the selective loss of high avidity subpopulation of PFC leaving low avidity subpopulation relatively unaffected. The degree of suppression in antibody avidity did not correlate with the reduction in the number of PFC, and thus causing the "shift" of avidity distribution of PFC to the low avidity end. These results indicate that the "maturation" of antibody in the T-cell-dependent antibody response is influenced by the carrier-specific suppressor T cells with respect to the emergence and selection of B cells having high affinity receptors for hapten. It is suggested that B cells binding antigen with high affinity receptors would be more easily affected than those with low affinity receptors by specific suppressor T cells which are capable of reacting the carrier portion of the same antigen.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4599880      PMCID: PMC2139704          DOI: 10.1084/jem.140.1.253

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.

Authors:  P J Baker; B Prescott; P W Stashak; D F Amsbaugh
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

2.  Effect of thymus-derived lymphocytes on amount and affinity of anti-hapten antibody.

Authors:  R K Gershon; W E Paul
Journal:  J Immunol       Date:  1971-03       Impact factor: 5.422

3.  Thymus dependence of antibody response: variation with dose of antigen and class of antibody.

Authors:  R B Taylor; H H Wortis
Journal:  Nature       Date:  1968-11-30       Impact factor: 49.962

4.  Determination of antibody-hapten equilibrium constants by an ammonium sulfate precipitation technique.

Authors:  Y Stupp; T Yoshida; W E Paul
Journal:  J Immunol       Date:  1969-09       Impact factor: 5.422

5.  The production and affinity of anti-hapten antibody under the influence of various inhibitory conditions.

Authors:  S Harel; S Ben-Efraim; P Liacopoulos
Journal:  Immunology       Date:  1970-08       Impact factor: 7.397

6.  Affinity of IgM and IgG antibodies.

Authors:  O Mäkelä; E Ruoslahti; I J Seppälä
Journal:  Immunochemistry       Date:  1970-11

7.  The anamnestic antibody response to type 3 specific pneumococcal polysaccharide.

Authors:  W E Paul; B Benacerraf; G W Siskind; D A Goidl; R A Reisfeld
Journal:  J Exp Med       Date:  1969-07-01       Impact factor: 14.307

8.  Specificity of cellular immune responses. Antigen concentration dependence of stimulation of DNA synthesis in vitro by specifically sensitized cells, as an expression of the binding characteristics of cellular antibody.

Authors:  W E Paul; G W Siskind; B Benacerraf
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

9.  Studies on the control of antibody synthesis. Interaction of antigenic competition and suppression of antibody formation by passive antibody on the immune response.

Authors:  N I Brody; J G Walker; G W Siskind
Journal:  J Exp Med       Date:  1967-07-01       Impact factor: 14.307

10.  The subunits in rabbit anti-Forssman IgM antibody.

Authors:  M M Frank; J H Humphrey
Journal:  J Exp Med       Date:  1968-05-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Innate response activator B cells: origins and functions.

Authors:  Benjamin G Chousterman; Filip K Swirski
Journal:  Int Immunol       Date:  2015-05-08       Impact factor: 4.823

2.  Antibody affinity maturation: the role of CD8+ cells.

Authors:  G P Holland; M W Steward
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

3.  Isoelectric focusing spectra of anti-bacterial alpha-amylase antibody unique for antigen-induced suppression.

Authors:  S Nakashima
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

4.  Suppression of antibody responses by cells from mice painted with picryl chloride.

Authors:  W R Thomas; M C Watkins; G L Asherson
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

5.  Age-dependent variations of antibody avidity.

Authors:  G Doria; G D'Agostaro; A Poretti
Journal:  Immunology       Date:  1978-10       Impact factor: 7.397

6.  Effect of carrier priming on antibody avidity in the in vivo and in vitro immune response.

Authors:  G Doria; G Agarossi; D Boraschi; M Antonietta
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

7.  Studies on the control of antibody synthesis. XVII. Effect of specific suppressor cells on the affinity of the antibody response by naive or primed lymphocytes.

Authors:  R H Dekruyff; R A Furie; G W Siskind
Journal:  Immunology       Date:  1980-06       Impact factor: 7.397

8.  Avidities of hapten-specific antibodies when the responses are modulated by anti-carrier antibodies.

Authors:  E Whited Collisson; B Andersson; E W Lamon
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

9.  Immunosuppression in murine malaria. III. Induction of tolerance and of immunological memory by soluble bovine serum albumin.

Authors:  J Strambachovà-McBride; H S Micklem
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

10.  Trypanosome infection of mice depresses antibody affinity and delays affinity maturation.

Authors:  J R Pattison; M W Steward; G A Targett
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.